The latest biotech news

cancer vaccine virus ervaxx cell therapy

News and Trends 17 Aug 2020

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced a Nasdaq IPO at €180M ($213M). The excitement around messenger RNA (mRNA) vaccines against Covid-19 could also benefit other players in mRNA therapeutics. CureVac’s IPO was priced at €14 ($16) per share, giving the German company a valuation of around […]

August 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Aug 2020

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

European companies developing advanced therapies such as gene and cell therapies secured at least €2.2B ($2.6B) in the first half of 2020. While this is encouraging in the face of Covid-19, it hasn’t been smooth sailing for all startups in the field, with many struggling to stay afloat during crippling national lockdowns. The funding received […]

August 14, 2020 - 5 minutesmins - By Victor Kotsev

News and Trends 13 Aug 2020

Why are Some European Biotechs Going Public Without an IPO?

European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all are going the traditional Initial Public Offering (IPO) route. What does this mean for the dominance of the biotech IPO in Europe? In spite of the Covid-19 pandemic, biotech IPOs have continued unabated. In fact, a report from Bioworld found […]

August 13, 2020 - 7 minutesmins - By Jonathan Smith

News and Trends 11 Aug 2020

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

With the help of a huge €66M Series A round last week, the German startup T-knife is developing cancer T-cell immunotherapies with the help of genetically modified mice. However, this is just one of several cancer T-cell therapy startups making advances this year, with other innovations including off-the-shelf treatments and a potential universal cancer therapy. […]

August 11, 2020 - 8 minutesmins - By Kostas Vavitsas

News and Trends 6 Aug 2020

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

The leading UK institution University College London and the firm AlbionVC have made the first closing of a €112M (£100M) fund with the aim of investing in UCL research and spinouts with a focus on gene and cell therapy. This is the second so-called UCL Technology Fund and could double the size of the first, […]

August 6, 2020 - 2 minutesmins - By Antara Mazumdar

News and Trends 6 Aug 2020

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

A request for market approval of a skin patch developed by French biotech DBV Technologies to treat peanut allergy has been turned down by the FDA, which has requested more data and design changes. The response from the FDA is a blow for the company which had been working towards getting the patch onto the […]

August 6, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Aug 2020

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

UK biotech Oxford Nanopore has launched a portable test that can detect both Covid-19 and seasonal flu viruses in saliva or swabs in a little over an hour. The quick output of Oxford Nanopore’s test, called LamPORE, is expected to be a huge improvement on existing polymerase chain reaction (PCR) tests, considered the gold standard […]

August 5, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 30 Jul 2020

Llama-Derived Nanobodies Join the Fight Against Covid-19

Newly-launched Belgian startup ExeVir Bio will develop ‘nanobodies’ that bind very precisely to key areas of the Covid-19 virus and other coronaviruses after raking in €23M in Series A. Based in Ghent, Belgium, ExeVir Bio is a spin-out of the research institute VIB established with the help of life sciences investor Fund+. Other investors include […]

July 30, 2020 - 3 minutesmins - By Victor Kotsev

News and Trends 29 Jul 2020

Covid-19 Forces Gene Therapy Companies to Shift Strategy

Amid the Covid-19 pandemic, gene therapy companies are suffering, with clinical trials delayed and investors remaining cautious in an increasingly volatile market. Yet many have set their sights on what could potentially turn into a gold mine: applying their technology to contain the spread of the novel coronavirus. The UK’s Cell and Gene Therapy Catapult […]

July 29, 2020 - 4 minutesmins - By Victor Kotsev

News and Trends 29 Jul 2020

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Update on 29/07/2020: DNA Script has increased the total raised in its Series B round to €80M ($89M). The additional funds will support the commercial launch of the company’s benchtop DNA printer, which is designed to allow same-day DNA synthesis directly in the lab bench. The company is planning to launch a beta testing program […]

July 29, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Jul 2020

Record Series A for Italian Biotech Funds Autoimmune Therapy

Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for type 1 diabetes and inflammatory bowel disease and take it to human trials. Enthera was founded in 2016 and is the first company to ‘graduate’ from the BiovelocITA accelerator program in Milan, which is supported by French life science investor […]

July 28, 2020 - 3 minutesmins - By Helen Albert

News and Trends 27 Jul 2020

Biological Fungicide Clears Wheat of Rust Disease in European Field Trial

A fungicide derived from amoeba has proven effective at protecting wheat from rust disease and other major fungal diseases at bay. Developed by French company Amoéba, this product could provide an eco-friendly solution to a growing problem in agriculture worldwide. Every year, over 5 million tons of wheat are lost to rust disease globally, which […]

July 27, 2020 - 2 minutesmins - By Kostas Vavitsas

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

Why are Some European Biotechs Going Public Without an IPO?

How European Startups Have Advanced Cancer T-Cell Therapy in 2020

€112M Fund Launched to Commercialize UCL’s Gene Therapy Research

DBV Technologies’ Peanut Allergy Patch Suffers FDA Setback

Oxford Nanopore’s Portable Covid-19 Test Launched in UK

Llama-Derived Nanobodies Join the Fight Against Covid-19

Covid-19 Forces Gene Therapy Companies to Shift Strategy

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Record Series A for Italian Biotech Funds Autoimmune Therapy

Biological Fungicide Clears Wheat of Rust Disease in European Field Trial

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!